Intraduodenal levodopa-carbidopa intestinal gel infusion improves both motor performance and quality of life in advanced Parkinson's disease

Journal of Clinical Neuroscience

Volumn 25, Issue , 2016, Pages 41-45

  Chang, Florence C F ^a   Kwan, Vu ^a   Van Der Poorten, David ^a   Mahant, Neil ^a   Wolfe, Nigel ^a   Ha, Ainhi D ^a   Griffith, Jane M ^a   Tsui, David ^a   Kim, Samuel D ^a   Fung, Victor S C ^a,b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Impulse control disorder; Levodopa carbidopa intestinal gel; Parkinson's disease; Peripheral neuropathy

Indexed keywords

CARBIDOPA PLUS LEVODOPA; ANTIPARKINSON AGENT; CARBIDOPA; DOPAMINE RECEPTOR STIMULATING AGENT; GEL; LEVODOPA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; DEMOGRAPHY; DIGESTIVE TUBE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXPERIMENTAL DOPAMINE DYSREGULATION SYNDROME; GASTROJEJUNAL TUBE; GEL; HUMAN; IATROGENIC DISEASE; IMPULSE CONTROL DISORDER; INTESTINAL BLEEDING; INTESTINE INFECTION; MALE; MEDICAL DEVICE COMPLICATION; MEDICAL HISTORY; MIDDLE AGED; MOTOR PERFORMANCE; PARKINSON DISEASE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PYRIDOXINE DEFICIENCY; QUALITY OF LIFE; RATING SCALE; SCORING SYSTEM; STOMA; TREATMENT DURATION; AGED; AUSTRALIA; CHEMICALLY INDUCED; CLINICAL TRIAL; DRUG EFFECTS; DUODENUM; DYSKINESIAS; FEMALE; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM DISEASES; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE;

ADULT; AGED; ANTIPARKINSON AGENTS; AUSTRALIA; CARBIDOPA; DOPAMINE AGENTS; DUODENUM; DYSKINESIAS; FEMALE; GELS; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; PROSPECTIVE STUDIES; PSYCHOMOTOR PERFORMANCE; QUALITY OF LIFE;

EID: 84956580714     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2015.05.059     Document Type: Article

References (25)

1. M.A. Hely, W.G. Reid, M.A. Adena, and et al. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years Mov Disord 23 2008 837 844
2. R. Kurlan, K.P. Rothfield, W.R. Woodward, and et al. Erratic gastric emptying of levodopa may cause "random" fluctuations of parkinsonian mobility Neurology 38 1988 419 421
3. J.G. Nutt, W.R. Woodward, J.P. Hammerstad, and et al. The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport N Engl J Med 310 1984 483 488
4. H.H. Fernandez, A. Vanagunas, P. Odin, and et al. Levodopa-carbidopa intestinal gel in advanced Parkinson's disease open-label study: interim results Parkinsonism Relat Disord 19 2013 339 345
5. H.H. Fernandez, D.G. Standaert, R.A. Hauser, and et al. Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results Mov Disord 30 2015 500 509
6. C.L. Tomlinson, R. Stowe, S. Patel, and et al. Systematic review of levodopa dose equivalency reporting in Parkinson's disease Mov Disord 25 2010 2649 2685
7. D. Nyholm, A.I. Nilsson Remahl, N. Dizdar, and et al. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease Neurology 64 2005 216 223
8. A. Antonini, I.U. Isaias, M. Canesi, and et al. Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome Mov Disord 22 2007 1145 1149
9. D. Nilsson, D. Nyholm, and S.M. Aquilonius Duodenal levodopa infusion in Parkinson's disease-long-term experience Acta Neurol Scand 104 2001 343 348
10. D. Nilsson, L.E. Hansson, K. Johansson, and et al. Long-term intraduodenal infusion of a water based levodopa-carbidopa dispersion in very advanced Parkinson's disease Acta Neurol Scand 97 1998 175 183
11. A. Antonini, F. Mancini, M. Canesi, and et al. Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease Neurodegener Dis 5 2008 244 246
12. V. Puente, O. De Fabregues, C. Oliveras, and et al. Eighteen month study of continuous intraduodenal levodopa infusion in patients with advanced Parkinson's disease: impact on control of fluctuations and quality of life Parkinsonism Relat Disord 16 2010 218 221
13. D. Santos-Garcia, L.F. Sanjurjo, M. Macias, and et al. Long-term exposure to duodenal levodopa/carbidopa infusion therapy improves quality of life in relation especially to mobility, activities of daily living, and emotional well-being Acta Neurol Scand 125 2012 187 191
14. C.W. Olanow, K. Kieburtz, P. Odin, and et al. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomized, controlled, double-blind, double-dummy study Lancet Neurol 13 2014 141 149
15. J. Volkmann, A. Albanese, A. Antonini, and et al. Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review J Neurol 260 2013 2701 2714
16. M.J. Catalan, E. de Pablo-Fernandez, C. Villanueva, and et al. Levodopa infusion improves impulsivity and dopamine dysregulation syndrome in Parkinson's disease Mov Disord 28 2013 2007 2010
17. P. Silberstein, R.G. Bittar, R. Boyle, and et al. Deep brain stimulation for Parkinson's disease: Australian referral guidelines J Clin Neurosci 16 2009 1001 1008
18. H. Honig, A. Antonini, P. Martinez-Martin, and et al. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life Mov Disord 24 2009 1468 1474
19. D. Weintraub, J. Koester, M.N. Potenza, and et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients Arch Neurol 67 2010 589 595
20. M.J. Frank, L.C. Seeberger, and R.C. O'Reilly By carrot or by stick: cognitive reinforcement learning in parkinsonism Science 306 2004 1940 1943
21. D. Nyholm, T. Lewander, A. Johansson, and et al. Enteral levodopa/carbidopa infusion in advanced Parkinson disease: long-term exposure Clin Neuropharmacol 31 2008 63 73
22. D. Santos-Garcia, M. Macias, M. Llaneza, and et al. Serum vitamin B(12) and folate levels in Parkinson's disease patients treated with duodenal levodopa infusion Mov Disord 26 2011 558 559
23. D. Manca, G. Cossu, D. Murgia, and et al. Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy Mov Disord 24 2009 2293 2294
24. F. Klostermann, C. Jugel, T. Muller, and et al. Malnutritional neuropathy under intestinal levodopa infusion J Neural Transm 119 2012 369 372
25. P.P. Urban, I. Wellach, S. Faiss, and et al. Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy Mov Disord 25 2010 1748 1752